Atea Pharmaceuticals Stock Future Price Prediction

AVIR -  USA Stock  

USD 26.23  0.90  3.32%

Atea Pharmaceuticals stock price prediction is an act of determining the future value of Atea Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Atea Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Atea Pharmaceuticals and does not consider all of the tangible or intangible factors available from Atea Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Atea Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please continue to Atea Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Atea Pharmaceuticals based on different types of headlines from major news networks to social media. The Atea Pharmaceuticals stock price prediction module provides an analysis of price elasticity to changes in media outlook on Atea Pharmaceuticals over a specific investment horizon. Using Atea Pharmaceuticals hype-based prediction, you can estimate the value of Atea Pharmaceuticals from the perspective of Atea Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Atea Pharmaceuticals Long Term Debt to Equity is relatively stable at the moment as compared to the past year. Atea Pharmaceuticals reported last year Long Term Debt to Equity of 0.00615. As of 09/19/2021, Accounts Payable Turnover is likely to grow to 51.90, while Receivables Turnover is likely to drop 13.11.
This module is based on analyzing investor sentiment around taking a position in Atea Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Atea Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Atea Pharmaceuticals because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Atea Pharmaceuticals after-hype prediction price

  $ 26.12  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Atea Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Atea Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
5 Analysts
LowTarget PriceHigh
Estimates (4)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Atea Pharmaceuticals. Your research has to be compared to or analyzed against Atea Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Atea Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Atea Pharmaceuticals.

Atea Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Atea Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Atea Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Atea Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Atea Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Atea Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Atea Pharmaceuticals' historical news coverage. Atea Pharmaceuticals' after-hype downside and upside margins for the prediction period are 21.57 and 30.67, respectively. We have considered Atea Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
19th of September 2021
After-hype Price
Atea Pharmaceuticals is not too volatile asset. Analysis and calculation of next after-hype price of Atea Pharmaceuticals is based on 3 months time horizon.

Atea Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Atea Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atea Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Atea Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.23  4.55  0.11   0.06  9 Events / Month6 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Atea Pharmaceuticals Hype Timeline

Atea Pharmaceuticals is presently traded for 26.23. The entity has historical hype elasticity of -0.11 and average elasticity to hype of competition of 0.06. Atea Pharmaceuticals is forecasted to decline in value after the next headline with price expected to drop to 26.12. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.42% whereas the daily expected return is presently at 0.23%. The volatility of related hype on Atea Pharmaceuticals is about 1820.0% with expected price after next announcement by competition of 26.29. About 18.0% of the company shares are held by company insiders. The book value of Atea Pharmaceuticals was presently reported as 13.09. The company recorded a loss per share of 0.64. Atea Pharmaceuticals next dividend is scheduled to be issued on the 9th of November 2012. The entity had 1:6 split on the 9th of November 2012. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 9 days.
Please continue to Atea Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Atea Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Atea Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Atea Pharmaceuticals' future price movements. Getting to know how Atea Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Atea Pharmaceuticals may potentially react to the hype associated with one of its peers.
At Risk
Equillium(0.22) 7 per month 3.40  0.0442  7.93 (5.99)  30.83 
Diamedica Therapeutics 0.14 9 per month 0.00 (0.13)  6.70 (7.87)  35.72 
Denali Therapeutics 0.93 10 per month 0.00 (0.15)  4.03 (4.75)  18.67 
Dicerna Pharmaceutic 0.33 9 per month 0.00 (0.15)  4.11 (5.30)  32.25 
Design Therapeutics(0.50) 9 per month 0.00 (0.12)  6.19 (7.81)  25.12 
Precision Biosciences 0.22 10 per month 3.33  0.09  6.58 (5.15)  24.86 
Dynavax Technologies 0.17 9 per month 4.20  0.19  7.82 (6.89)  29.34 
Dyadic International 0.31 9 per month 4.47  0.12  12.24 (8.78)  61.31 
Editas Medicine 1.21 8 per month 3.65  0.19  9.42 (5.15)  35.18 
Edesa Biotech(0.09) 5 per month 2.51  0.032  4.93 (4.54)  17.46 

Atea Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Atea Pharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Atea Pharmaceuticals using various technical indicators. When you analyze Atea Pharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Atea Pharmaceuticals Predictive Indicators

The successful prediction of Atea Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Atea Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Atea Pharmaceuticals based on analysis of Atea Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Atea Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Atea Pharmaceuticals's related companies.
 2015 2016 2020 2021 (projected)
PPandE Turnover37.135.649.342.93
Long Term Debt to Equity0.0064940.0053480.006150.007743

Story Coverage note for Atea Pharmaceuticals

The number of cover stories for Atea Pharmaceuticals depends on current market conditions and Atea Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Atea Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Atea Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Atea Pharmaceuticals Short Properties

Atea Pharmaceuticals' future price predictability will typically decrease when Atea Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Atea Pharmaceuticals often depends not only on the future outlook of the potential Atea Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atea Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out5.14%
Short Percent Of Float5.66%
Float Shares49.08M
Shares Short Prior Month2.24M
Average Daily Volume Last 10 Day1.52M
Average Daily Volume In Three Month1.4M
Date Short Interest15th of April 2021
Please continue to Atea Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.